Profound Medical (PROF) Total Non-Current Liabilities (2018 - 2026)
Profound Medical (PROF) posted quarterly Total Non-Current Liabilities of $13.9 million for Q1 2026, up 39.37% year-over-year from $10.0 million in Q1 2025, and up 27.17% quarter-over-quarter from $11.0 million in Q4 2025.
Profound Medical (PROF) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Profound Medical's Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $13.9 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 39.37% year-over-year to $13.9 million; the TTM figure through Mar 2026 stood at $13.9 million (up 39.37% YoY), while the FY2025 annual figure was $11.0 million, up 12.53% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $13.9 million, up from $11.0 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $13.9 million in Q1 2026, with the low at $9.7 million in Q4 2024.
- The 4-year median for Total Non-Current Liabilities is $10.3 million (2025), against an average of $11.1 million.
- The sharpest annual moves came in 2024 and 2026: Total Non-Current Liabilities retreated 23.05% in 2024, then soared 39.37% in 2026.
- Profound Medical's Total Non-Current Liabilities stood at $12.7 million in 2023, then dropped by 23.05% to $9.7 million in 2024, then climbed by 12.53% to $11.0 million in 2025, then increased by 27.17% to $13.9 million in 2026.
- Business Quant data shows PROF's Total Non-Current Liabilities at $13.9 million in Q1 2026, $11.0 million in Q4 2025, and $10.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Profound Medical | 241.00 Mn | 202.73 Mn | 1.95 Mn | 12.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.49 Mn |
| Mar 31, 2026 | 13.94 Mn |
| Dec 31, 2025 | 10.96 Mn |
| Sep 30, 2025 | 10.09 Mn |
| Jun 30, 2025 | 10.33 Mn |
| Mar 31, 2025 | 10.00 Mn |
| Dec 31, 2024 | 9.74 Mn |
| Dec 31, 2023 | 12.66 Mn |
| Dec 31, 2020 | 7.15 Mn |
| Dec 31, 2019 | 15.22 Mn |
| Jan 1, 2019 | 13.87 Mn |
| Dec 31, 2018 | 14.34 Mn |